| Autor: |
Tharp WG; Department of Anesthesiology, University of Vermont, Burlington, Vermont, United States., Morris CR; Department of Medicine, University of Vermont, Burlington, Vermont, United States., Santos-Ortega Y; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, United States., Vary CP; Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, United States.; University of Maine Graduate School of Biomedical Science and Engineering, University of Maine, Orono, Maine, United States.; School of Medicine, Tufts University, Boston, Massachusetts, United States., Bender SP; Department of Anesthesiology, University of Vermont, Burlington, Vermont, United States., Dixon AE; Department of Medicine, University of Vermont, Burlington, Vermont, United States. |
| Abstrakt: |
Obesity may lead to pulmonary dysfunction through complex and incompletely understood cellular and biochemical effects. Altered lung lipid metabolism has been identified as a potential mechanism of lung dysfunction in obesity. Although murine models of obesity demonstrate changes in pulmonary surfactant phospholipid composition and function, data in humans are lacking. We measured untargeted shotgun lipidomes in two bronchoalveolar lavages (BALs) from apical and anteromedial pulmonary subsegments of 14 adult subjects (7 males and 7 females) with body mass indexes (BMIs) ranging from 24.3 to 50.9 kg/m 2 . The lipidome composition was characterized at the class, species, and fatty acyl/alkyl level using total lipid molecular ion signal intensities normalized to BAL protein concentration and epithelial lining fluid volumes. Multivariate analyses were conducted to identify potential changes with increasing BMI. The alveolar lipidomes contained the expected composition of surfactant-associated phospholipids, sphingolipids, and sterols in addition to cardiolipin and intracellular signaling lipid species. No significant differences in lipidomes were detected between the two BAL regions. Though a small number of lipid species were associated with BMI in multivariate analyses, no robust differences in lipidome composition or specific lipid species were identified over the range of body habitus. The magnitude of obesity alone does not substantially alter the alveolar lipidome in patients without lung disease. Differences in lung function in patients with obesity and no lung disease are unlikely related to changes in alveolar lipid composition. NEW & NOTEWORTHY Altered lung lipid metabolism has been identified as a potential mechanism of lung dysfunction in obesity, but data in humans are lacking. We measured the alveolar lipidome in bronchoalveolar lavages from subjects with healthy lungs with a wide range of body mass index. There were no differences in lipidome composition in association with the magnitude of obesity. In patients with healthy lungs, obesity alone does not alter the alveolar lipidome. |
